Additionally, the combined expression of c-MET and MMP10 further exacerbates prognosis, with patients showing dual-positive expression experiencing worse outcomes in CCA (Figure 6D and Supplementary Tables S6–S8). The gene discussed is MET; the disease is cholangiocarcinoma.